Scott J Moeller
Overview
Explore the profile of Scott J Moeller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
1725
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Perlman G, Wengler K, Moeller S, Kotov R, Klein D, Weinstein J, et al.
Am J Psychiatry
. 2024 Oct;
181(11):997-1005.
PMID: 39380373
Objective: Midbrain dopamine function plays a key role in translational models of substance use disorders. Whether midbrain dopamine function is associated with substance use frequency and severity or reward function...
2.
Slifstein M, Qu W, Gil R, Weinstein J, Perlman G, Jaworski-Calara T, et al.
Neuropsychopharmacology
. 2024 Aug;
49(13):2087-2093.
PMID: 39217267
The kappa opioid receptor (KOR) and its endogenous agonist dynorphin have been implicated in multiple psychiatric conditions including psychotic disorders. We tested the hypotheses that kappa expression is elevated and...
3.
Moeller S, Abeykoon S, Dhayagude P, Varnas B, Weinstein J, Perlman G, et al.
Biol Psychiatry Cogn Neurosci Neuroimaging
. 2024 Jul;
9(11):1211-1221.
PMID: 39059467
Background: Individuals with substance use disorder show impaired self-awareness of ongoing behavior. This deficit suggests problems with metacognition, which has been operationalized in the cognitive neuroscience literature as the ability...
4.
Tobacco Images Choice and its Association With Craving and Dependence in People Who Smoke Cigarettes
Solinas M, Chauvet C, Lafay-Chebassier C, Vanderkam P, Barillot L, Moeller S, et al.
Nicotine Tob Res
. 2024 Jun;
26(12):1636-1645.
PMID: 38850196
Introduction: Increased salience of drug-related cues over nondrug reinforcers can drive drug use and contribute to tobacco use disorder (TUD). An important scientific and clinical goal is to effectively measure...
5.
Weinstein J, Moeller S, Perlman G, Gil R, Van Snellenberg J, Wengler K, et al.
Biol Psychiatry
. 2024 Feb;
96(5):352-364.
PMID: 38309322
Background: Despite longstanding interest in the central cholinergic system in schizophrenia (SCZ), cholinergic imaging studies with patients have been limited to receptors. Here, we conducted a proof-of-concept positron emission tomography...
6.
Konova A, Ceceli A, Horga G, Moeller S, Alia-Klein N, Goldstein R
Neuron
. 2023 Oct;
111(24):4058-4070.e6.
PMID: 37883973
Influential accounts of addiction posit alterations in adaptive behavior driven by deficient dopaminergic prediction errors (PEs), signaling the discrepancy between actual and expected reward. Dopamine neurons encode these error signals...
7.
Solinas M, Chauvet C, Lafay-Chebassier C, Vanderkam P, Barillot L, Moeller S, et al.
bioRxiv
. 2023 Sep;
PMID: 37693420
Introduction: Increased salience of drug-related cues over non-drug reinforcers can drive drug use and contribute to tobacco use disorder (TUD). An important scientific and clinical goal is to effectively measure...
8.
Macatee R, Schermitzler B, Minieri J, Moeller S, Afshar K, Preston T
Addiction
. 2023 Aug;
118(12):2397-2412.
PMID: 37612599
Background And Aims: Cannabis use disorder (CUD) prevalence has increased, while perceived risks of cannabis use and CUD treatment need have decreased. Chronic cannabis use may also impair the neural...
9.
Zilverstand A, Parvaz M, Moeller S, Kalayci S, Kundu P, Malaker P, et al.
Mol Psychiatry
. 2023 Aug;
28(8):3355-3364.
PMID: 37528227
Lapses in inhibitory control have been linked to relapse in human drug addiction. Evidence suggests differences in inhibitory control depending on abstinence duration, but the underlying neural mechanisms remain unknown....
10.
Abi-Dargham A, Moeller S, Ali F, DeLorenzo C, Domschke K, Horga G, et al.
World Psychiatry
. 2023 May;
22(2):236-262.
PMID: 37159365
The field of psychiatry is hampered by a lack of robust, reliable and valid biomarkers that can aid in objectively diagnosing patients and providing individualized treatment recommendations. Here we review...